China Life Insurance (HKG:2628) First Quarter 2025 Results
Key Financial Results
- Revenue: CN¥64.3b (down 11% from 1Q 2024).
- Net income: CN¥28.8b (up 40% from 1Q 2024).
- Profit margin: 45% (up from 29% in 1Q 2024). The increase in margin was driven by lower expenses.
- EPS: CN¥1.02 (up from CN¥0.73 in 1Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
China Life Insurance Earnings Insights
Looking ahead, revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Insurance industry in Hong Kong.
Performance of the Hong Kong Insurance industry.
The company's shares are up 1.4% from a week ago.
Risk Analysis
You still need to take note of risks, for example - China Life Insurance has 2 warning signs (and 1 which shouldn't be ignored) we think you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.